936633-36-2

Upstream product

• 936633-22-6 N-{4-[2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-piperidin-4-yl}-3-[4-(di-tert-butoxy-phosphorylmethyl)-benzyl]-succinamic acid tert-butyl ester 
• 57913-41-4 2-phenylethyl chloroformate 
• 220193-50-0 3-(naphth-1-yl)propanamido-N-(tert-butoxycarbonyl)-L-asparagine 
• 284677-41-4 (S)-asparagine-3-((1-naphthyl)propyl)amide 
• 936633-20-4 4-{2-tert-butoxycarbonylmethyl-3-[4-(di-tert-butoxy-phosphorylmethyl)-phenyl]-propionylamino}-4-[2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-piperidine-1-carboxylic acid benzyl ester 
• 936633-15-7 4-amino-4-[2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-piperidine-1-carboxylic acid benzyl ester 

Relevant academic research and scientific papers

Examination of acylated 4-aminopiperidine-4-carboxylic acid residues in the phosphotyrosyl+1 position of Grb2 SH2 domain-binding tripeptides

A 4-aminopiperidine-4-carboxylic acid residue was placed in the pTyr+1 position of a Grb2 SH2 domain-binding peptide to form a general platform, which was then acylated with a variety of groups to yield a library of compounds designed to explore potential